On this episode of Ropes & Gray’s podcast series Controlling Opinions, life sciences regulatory and compliance partner Josh Oyster and counsel Beth Weinman are joined by health care partner Brett Friedman and litigation and...more
2/11/2025
/ Cannabis Products ,
Controlled Substances ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Health Care Providers ,
Life Sciences ,
Prescription Drugs ,
Regulatory Agenda ,
Telemedicine ,
Trump Administration
On November 26, 2024, Centers for Medicare & Medicaid Services (“CMS”) released a proposed rule revising the Medicare Advantage (“MA”) Program (Part C), Medicare Prescription Drug Benefit Program (Part D), Medicare Cost Plan...more
12/10/2024
/ Artificial Intelligence ,
Beneficiaries ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Review Act ,
Cost-Sharing ,
Marketing ,
Medicare ,
Medicare Advantage ,
Open Enrollment ,
PACE ,
Proposed Rules ,
Transparency ,
Trump Administration